Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1995-06-05
1998-07-07
Elliott, George C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424 932, 424 934, 4242481, 4242821, 435 691, 435 6952, 4351723, 4352523, 4352531, A61K 3904, A61K 4505, C12N 121
Patent
active
057764654
ABSTRACT:
The present invention relates to recombinant mycobacteria, particularly recombinant M. bovis BCG, which express heterologous DNA encoding a product (protein or polypeptide) of interest, such a protein or polypeptide (e.g., an antigen) against which an immune response is desired, or a cytokine.
REFERENCES:
Huygen, K., et al., "Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice," Infect. Immun., 60:2880-2886 (1992).
Ratliff, T. L., et al., "Requirement of a thymus dependent immune response for BCG-mediated antitumor activity," J. Urol., 137:155-158 (1987).
Sasaki, H., et al., "Induction of interleukin-3 and tumor resistance by SSM, a cancer immunotherapeutic agent extracted from Mycobacterium tuberculosis," Cancer Res., 50:4032-4037 (1990).
Wallis, R. S., et al., "Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot," Proc. Natl. Acad. Sci., 87:3348-3352 (1990).
Wolfe, S. A., et al., "Induction of `natural killer` cells by BCG," Nature, 262:584-586 (1976).
Yamamura, M., et al., "Defining protective responses to pathogens: cytokine profiles in leprosy lesions," Science, 254:277-279 (1991).
Heinzel, F.P., et al., "Reciprocal expression of interferon-.gamma. or interleukin-4 during resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subset," J. Exp. Med., 169:59-72 (1989).
Prescott, S., et al., "Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall, " J. Urol., 147:1636-1642 (1992).
Born, W., et al., "Recognition of heat shock proteins and .gamma..delta. cell function," Immunol. Today, 11:40-43 (1990).
Bloom, W. H., et al., "Human mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes," Infect. and Immun., 59:2737-2743 (1991).
Del Prete, G.F., et al., "Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production," J. Clin. Invest., 88:346-350 (1991).
Inoue, T. et al., "Early appearing .gamma./.delta. Bearing T cells during infection with Calmette Guerin Bacillus," J. Immunol., 146:2754-2762 (1991).
Matsuo, K. et al., "Cloning and expression of the mycobacterium bovis BCG gene for the extracellular alpha antigen," J. Bacter., 170:3847-3854 (1988).
Matsuo, K. et al., "Establishment of a foreign antigen secretion system in mycobacteria," Infect. Immun., 58:4049-4054 (1990).
Carrier, M. J. et al., "Expression of Human IL-1 .beta. in Salmonella typhonuorium. A model system for the delivery of recombinant therapeutic proteins in vivo," J. Immunol., 148:1176-1781 (1992).
Ramshaw, I. et al., "Expression of cytokines by recombinant vaccinia viruses: A model for studying cytokines in virus infections in vivo," Immunol. Rev., 127:157-182 (1992).
Ramakrishnan, T. and Shaila, M.S., "Interfamilial Transfer of Amber Suppressor Gene for the Isolation of Amber Mutants of Mycobacteriophage I3", Arch. Microbiol., 120:301-302 (1979).
O'Donnell, M.A., et al., "Secretion of IL-2 after transfection of rIL-2 gene into BCG", Proc. Amer. Assoc. Cancer Res. Ann. Meet., 34(0) (1993). 84th annual meeting, Orlando, Fl., USA, May 19-22, 1993.
O'Donnell, M.A., et al., "Construction of interleukin-2 secreting BCG", J. Urol., 149(4 suppl.) :270A (1993) 88th annual meeting of the Am. Urol. Soc., San Antonio, TX, May 15-20, 1993.
O'Donnell, M.A., et al., "Recombinant Mycobacterium bovis BCG Secreting Functional Interleukin-2 Enhances Gamma Interferon Production by Splenocytes", Infect. Immun. 62(6) :2508-2514 (Jun. 1994).
Aldovini, A. and Young, R.A., "Humoral and cell mediated immune responses to live recombinant BCG-HIV vaccines", Nature 351:479-484 (1991).
Labidi, A., et al., "Cloning and expression of mycobacterial plasmid DNA in Escherichia coli", FEMS Microbiol. Lett., 30:221-225 (1985).
Labidi, A., et al., "Restriction Endonuclease Mapping and Cloning of Mycobacterium Fortuitum Var. Fortuitum Plasmid pAL5000", Ann. Inst. Pasteur/Microbiol., 136B:209-215 (1985).
Jacobs, W.R., et al., "Introduction of foreign DNA into mycobacteria using a shuttle phasmid", Nature, 327:532-535 (1987).
Norgard, M.V., and Imaeda, T., "Physiological Factors Involved in the Transformation of Mycobacterium smegmatis", et al., J. Bacteriol., 133(3):1254-1262 (1978).
Burke, J.F., et al., "An assay for transient gene expression in Drosophila (1984).
Lindquist, S., et al., "The Heat Shock Proteins", Ann. Rev. Genet., 22:631-677 (1988).
Lathigra, R.B., et al., "A gene from Mycobacterium tuberculosis which is homologous to the DnaJ heat shock protein pf E. coli", Nucleic Acids Res., 16(4):1636 (1988).
Thole, et al., "Characterization, Sequence Determination, and Immunogenicity of a 64-Kilodalton Protein of Mycobacterium bovis BCG Expressed in Escherichia coli K-12", Infect. and Imm., 55(6):1466-1475 (1987).
Aldovini Anna
DeWolf William C.
Duda Rosemary B.
O'Donnell Michael A.
Young Richard A.
Beth Israel Hospital Association
Elliott George C.
Railey II Johnny F.
Whitehead Institute for Biomedical Research
LandOfFree
Recombinant mycobacterial vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant mycobacterial vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant mycobacterial vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1202617